Stockscreener 앱 받기
16.85
0.24%
-0.04
시장 영업 전:
16.80
-0.05
-0.30%
Tourmaline Bio Inc 주식(TRML)의 최신 뉴스
Chardan Capital Weighs in on Tourmaline Bio FY2025 Earnings - Defense World
Chardan Capital Begins Coverage on Tourmaline Bio (NASDAQ:TRML) - Defense World
Ready to Jump After Recent Trade: Tourmaline Bio Inc (TRML) - Sete News
An analyst sees good growth prospects for New Fortress Energy Inc (NFE) - Sete News
TRML Stock Sees Surge of Approximately 19.36% in Last Five Days - knoxdaily.com
Chardan sets $70 target on Tourmaline Bio, cites lead asset By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Overweight on Tourmaline Bio stock By Investing.com - Investing.com Canada
Chardan Capital Initiates Coverage of Tourmaline Bio (TRML) with Buy Recommendation - MSN
Investing in Tourmaline Bio Inc (TRML) might be an excellent idea, but the stock is currently overvalued/undervalued - uspostnews.com
BARK Inc (BARK) did well last session? - uspostnews.com
STRL (Sterling Infrastructure Inc) has impressive results - uspostnews.com
Chardan Initiates Tourmaline Bio at Buy With $70 Price Target - marketscreener.com
Alliancebernstein L.P. Has $263,000 Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights - ADVFN
Here's Why We're Not Too Worried About Tourmaline Bio's (NASDAQ:TRML) Cash Burn Situation - Yahoo Finance
Pre-market Movers: CHRO, QURE, FOTA, LLY... - RTTNews
Vanguard Group Inc. Boosts Stock Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Equity LifeStyle Properties, Inc. (NYSE:ELS) Position Boosted by Wellington Management Group LLP - Defense World
Wellington Management Group LLP Buys Shares of 114,300 Vodafone Group Public Limited (NASDAQ:VOD) - Defense World
Wellington Management Group LLP Buys 8,001 Shares of Altimmune, Inc. (NASDAQ:ALT) - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Stock Position Increased by Wellington Management Group LLP - Defense World
Wellington Management Group LLP Acquires 813 Shares of Ferrovial SE (NASDAQ:FER) - Defense World
Corebridge Financial Inc. Trims Holdings in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Wellington Management Group LLP Raises Position in Nuvation Bio Inc. (NYSE:NUVB) - Defense World
Corebridge Financial Inc. Has $199,000 Holdings in Red Violet, Inc. (NASDAQ:RDVT) - Defense World
KLP Kapitalforvaltning AS Invests $47,000 in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Corebridge Financial Inc. Lowers Position in Chatham Lodging Trust (NYSE:CLDT) - Defense World
Franklin Resources Inc. Sells 5,012 Shares of Genworth Financial, Inc. (NYSE:GNW) - Defense World
7,700 Shares in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Acquired by KLP Kapitalforvaltning AS - Defense World
Corebridge Financial Inc. Has $213,000 Position in Celcuity Inc. (NASDAQ:CELC) - Defense World
Franklin Resources Inc. Decreases Stake in Heidrick & Struggles International, Inc. (NASDAQ:HSII) - Defense World
Vanguard Group Inc. Raises Stock Position in Wave Life Sciences Ltd. (NASDAQ:WVE) - Defense World
Elme Communities (NYSE:ELME) Shares Bought by American Century Companies Inc. - Defense World
Norges Bank Makes New Investment in Fractyl Health, Inc. (NASDAQ:GUTS) - Defense World
Can TRANQUILITY Data Propel Tourmaline Bio's Stock Price? - RTTNews
Truist Cuts Price Target on Tourmaline Bio to $63 From $74, Keeps Buy Rating - marketscreener.com
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Rating of “Buy” by Brokerages - Defense World
Talaris Therapeutics stock hits 52-week low at $11.85 By Investing.com - Investing.com Canada
Prudential Financial Inc. Cuts Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Rovida Advisors Inc. Boosts Stake in Alphabet Inc. (NASDAQ:GOOGL) - Defense World
Tourmaline Bio: We Should Wait For Upcoming Phase 2b Trial Data - Seeking Alpha
Should You Invest in H&R Block Inc (HRB) Now? - News Heater
Swiss National Bank Takes Position in Tourmaline Bio, Inc. (NASDAQ:TRML) - Defense World
Leading Factor Driving the Thyroid Eye Disease (TED) Market in 2025: Thyroid Disorders And Their Influence ... - WhaTech
ProfittoPath - TradingView
Tourmaline Bio, Inc. (NASDAQ:TRML) Shares Sold by AlphaQuest LLC - Defense World
Tourmaline Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Alumis Inc. (NASDAQ:ALMS) Receives Average Recommendation of “Buy” from Brokerages - Defense World
Tourmaline Bio, Inc. (NASDAQ:TRML) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Tourmaline Bio (NASDAQ:TRML) Stock Price Expected to Rise, Wedbush Analyst Says - Defense World
HC Wainwright Raises Tourmaline Bio (NASDAQ:TRML) Price Target to $50.00 - Defense World
H.C. Wainwright raises Tourmaline Bio stock target to $50 By Investing.com - Investing.com Canada
Tourmaline Bio price target raised to $43 from $42 at Wedbush - TipRanks
H.C. Wainwright raises Tourmaline Bio stock target to $50 - Investing.com India
Wedbush Lifts Price Target on Tourmaline Bio to $43 From $42, Keeps Outperform Rating - Marketscreener.com
Novo Nordisk (0QIU) Gets a Buy from UBS - The Globe and Mail
Tourmaline Bio’s 2024 Financial Results and Strategic Advances - TipRanks
Tourmaline Bio shares fall as Q4 loss widens - Investing.com
Tourmaline Bio shares fall as Q4 loss widens By Investing.com - Investing.com UK
TOURMALINE BIO Earnings Results: $TRML Reports Quarterly Earnings - Nasdaq
Tourmaline Bio, Inc. SEC 10-K Report - TradingView
Tourmaline Bio's cash position to provide cash runway into second half of 2027 -March 13, 2025 at 07:39 am EDT - Marketscreener.com
Tourmaline Bio, Inc. Announces Over-Enrolled Phase 2 TRANQUILITY Trial and Strengthens Cardiovascular Scientific Advisory Board Amid Positive Financial Outlook - Nasdaq
Tourmaline Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business - Bluefield Daily Telegraph
Tourmaline Bio Secures 2.5-Year Cash Runway with $294M, Accelerates Key Clinical Trials - StockTitan
Tourmaline Bio (TRML) Projected to Post Earnings on Tuesday - Defense World
Wedbush Forecasts Tourmaline Bio FY2024 Earnings - Defense World
0.19%
자본화:
|
볼륨(24시간):